We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$20.7B
AUM Growth
-$166M
Cap. Flow
-$582M
Cap. Flow %
-2.82%
Top 10 Hldgs %
30.44%
Holding
2,896
New
52
Increased
415
Reduced
1,909
Closed
89

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$65.1M
2
AAPL icon
Apple
AAPL
+$58M
3
MSFT icon
Microsoft
MSFT
+$49.2M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$25.9M
5
AL
Air Lease Corp
AL
+$21.6M

Sector Composition

Rank Sector Weight
1 Technology 30.28%
2 Financials 13.29%
3 Healthcare 10.43%
4 Consumer Discretionary 10.39%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNFI icon
1351
United Natural Foods
UNFI
$2.9B
$1.13M 0.01%
33,653
-1,275
-4% -$47.4K
AVPT icon
1352
AvePoint
AVPT
$2.91B
$1.13M 0.01%
81,560
+2,395
+3% +$33.1K
ACMR icon
1353
ACM Research
ACMR
$5.65B
$1.13M 0.01%
28,640
-2,037
-7% -$75.9K
EFSC icon
1354
Enterprise Financial Services Corp
EFSC
$2.41B
$1.13M 0.01%
20,872
-827
-4% -$45.4K
EYE icon
1355
National Vision
EYE
$1.54B
$1.12M 0.01%
43,467
-1,991
-4% -$53.6K
TIC
1356
TIC Solutions Inc
TIC
$2.22B
$1.12M 0.01%
110,799
+8,535
+8% +$95K
QGEN icon
1357
Qiagen
QGEN
$8.93B
$1.12M 0.01%
24,601
-66
-0.3% -$3.05K
FLO icon
1358
Flowers Foods
FLO
$1.6B
$1.12M 0.01%
102,787
-5,326
-5% -$61.8K
IMNM icon
1359
Immunome
IMNM
$3.18B
$1.12M 0.01%
52,034
+9,623
+23% +$169K
INSW icon
1360
International Seaways
INSW
$4.71B
$1.12M 0.01%
23,001
-1,041
-4% -$51.5K
XRAY icon
1361
Dentsply Sirona
XRAY
$2.31B
$1.11M 0.01%
97,500
-5,024
-5% -$59K
BUSE icon
1362
First Busey Corp
BUSE
$2.58B
$1.11M 0.01%
46,706
-3,526
-7% -$82.9K
CXW icon
1363
CoreCivic
CXW
$3.32B
$1.11M 0.01%
58,015
-7,288
-11% -$134K
ADUS icon
1364
Addus HomeCare
ADUS
$2.2B
$1.11M 0.01%
10,318
-407
-4% -$46.7K
WD icon
1365
Walker & Dunlop
WD
$1.45B
$1.1M 0.01%
18,349
-772
-4% -$54.8K
WVE icon
1366
Wave Life Sciences
WVE
$1.02B
$1.1M 0.01%
64,763
+5,557
+9% +$56.5K
IRON icon
1367
Disc Medicine
IRON
$3.07B
$1.1M 0.01%
13,832
-90
-0.6% -$7.61K
CTRI icon
1368
Centuri Holdings
CTRI
$2.4B
$1.1M 0.01%
43,488
+2,185
+5% +$48.9K
MTX icon
1369
Minerals Technologies
MTX
$2.25B
$1.1M 0.01%
18,000
GRBK icon
1370
Green Brick Partners
GRBK
$3.02B
$1.1M 0.01%
17,501
-1,155
-6% -$76.1K
CAR icon
1371
Avis
CAR
$4.93B
$1.09M 0.01%
8,533
-424
-5% -$59.2K
AVDL
1372
DELISTED
Avadel Pharmaceuticals
AVDL
$1.09M 0.01%
50,708
-5,253
-9% -$102K
IOSP icon
1373
Innospec
IOSP
$2.31B
$1.09M 0.01%
14,256
-633
-4% -$47.8K
SGHC icon
1374
SGHC Ltd
SGHC
$6.51B
$1.09M 0.01%
91,217
-4,633
-5% -$55.7K
BF.B icon
1375
Brown-Forman Class B
BF.B
$12.8B
$1.09M 0.01%
41,746
-1,469
-3% -$41.3K

Similar funds

MetLife Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, MetLife Investment Management held 2,896 positions worth $20.7B, down 0.8% from $20.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 4.9%. MetLife Investment Management opened 52 new positions and exited 89, leaving the 2,896-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2025 buy was RTX Corp: 321,368 shares worth $58.9M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $54.6M increase.
  • MetLife Investment Management's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $65.1M.
  • MetLife Investment Management fully exited Kellanova in Q4 2025, selling an estimated $5.48M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $20.7B portfolio in Q4 2025.
  • MetLife Investment Management opened 52 new positions and closed 89 in Q4 2025.
  • MetLife Investment Management's portfolio value fell 0.8% quarter-over-quarter to $20.7B.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.